Biomimetic Keratin-Coated Gold Nanoparticles for Photo-Thermal Therapy in a 3D Bioprinted Glioblastoma Tumor Model.
3D bioprinting
cancer
optics
photo-thermal therapy
plasmonics
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
23 Aug 2022
23 Aug 2022
Historique:
received:
04
08
2022
revised:
19
08
2022
accepted:
19
08
2022
entrez:
9
9
2022
pubmed:
10
9
2022
medline:
14
9
2022
Statut:
epublish
Résumé
Before entering human clinical studies to evaluate their safety and effectiveness, new drugs and novel medical treatments are subject to extensive animal testing that are expensive and time-consuming. By contrast, advanced technologies enable the development of animal-free models that allow the efficacy of innovative therapies to be studied without sacrificing animals, while providing helpful information and details. We report on the powerful combination of 3D bioprinting (3DB) and photo-thermal therapy (PTT) applications. To this end, we realize a 3DB construct consisting of glioblastoma U87-MG cells in a 3D geometry, incorporating biomimetic keratin-coated gold nanoparticles (Ker-AuNPs) as a photo-thermal agent. The resulting plasmonic 3DB structures exhibit a homogeneous cell distribution throughout the entire volume while promoting the localization of Ker-AuNPs within the cells. A 3D immunofluorescence assay and transmission electron microscopy (TEM) confirm the uniform distribution of fluorescent-labeled Ker-AuNPs in the volume and their capability to enter the cells. Laser-assisted (λ = 532 nm) PTT experiments demonstrate the extraordinary ability of Ker-AuNPs to generate heating, producing the highest temperature rise of about 16 °C in less than 2 min.
Identifiants
pubmed: 36076927
pii: ijms23179528
doi: 10.3390/ijms23179528
pmc: PMC9455633
pii:
doi:
Substances chimiques
Keratins
68238-35-7
Gold
7440-57-5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : POR FESR LAZIO 2014-2020
ID : 28166
Organisme : Sapienza University of Rome
ID : RM11816431206A2C
Organisme : Sapienza University of Rome
ID : RM120172B2E7CDAF
Références
Biofabrication. 2021 Apr 07;13(3):
pubmed: 33434889
Toxicol Mech Methods. 2021 Jan;31(1):1-17
pubmed: 32972312
Sci Rep. 2020 Aug 18;10(1):14023
pubmed: 32811864
J Biomed Mater Res A. 2019 Aug;107(8):1702-1712
pubmed: 30920169
J Control Release. 2022 Jul 9;349:269-303
pubmed: 35787915
J Mater Chem B. 2019 Nov 28;7(44):6924-6933
pubmed: 31638633
Nanomaterials (Basel). 2022 Jul 24;12(15):
pubmed: 35893513
J Phys Chem B. 2006 Aug 17;110(32):15700-7
pubmed: 16898714
Food Chem Toxicol. 2017 Oct;108(Pt A):63-73
pubmed: 28713048
Photodiagnosis Photodyn Ther. 2018 Mar;21:201-210
pubmed: 29223737
Mater Sci Eng C Mater Biol Appl. 2020 Feb;107:110264
pubmed: 31761183
Nat Commun. 2018 Mar 14;9(1):1074
pubmed: 29540781
Chem Soc Rev. 2019 Apr 1;48(7):2053-2108
pubmed: 30259015
Cytotechnology. 2018 Feb;70(1):261-273
pubmed: 28924965
Colloids Surf B Biointerfaces. 2020 Oct;194:111213
pubmed: 32622254
Sci Rep. 2018 Sep 10;8(1):13532
pubmed: 30201959
J Nanobiotechnology. 2021 Oct 24;19(1):335
pubmed: 34689765
Nanomedicine (Lond). 2021 Jan;16(2):121-138
pubmed: 33426900
Theranostics. 2016 Mar 21;6(6):762-72
pubmed: 27162548
BMC Mol Cell Biol. 2022 Mar 7;23(1):13
pubmed: 35255831
Front Chem. 2019 Apr 05;7:167
pubmed: 31024882
J Mater Chem B. 2020 Mar 4;8(9):1823-1840
pubmed: 32067013
Urol J. 2017 Jul 02;14(4):4038-4043
pubmed: 28670673
Cell Prolif. 2021 Mar;54(3):e12993
pubmed: 33458899
Int J Nanomedicine. 2019 Aug 09;14:6387-6406
pubmed: 31496693
Int J Mol Sci. 2022 Jul 18;23(14):
pubmed: 35887248
Nanomedicine (Lond). 2010 Oct;5(8):1161-71
pubmed: 21039194